FNY Investment Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

FNY Investment Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-51,000	Closed	-$1.69M	–	832
2022 Q4	$1.69M	Buy	+51,000	New	+$1.64M	2.36%	7
2019 Q1	–	Sell	-577	Closed	-$10K	–	1020
2018 Q4	$10K	Buy	+577	New	+$9.84K	﹤0.01%	459

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's VIVO Position: Q1 2023 in Review

FNY Investment Advisers sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 51,000 shares — an estimated $1.69M sold.

FNY Investment Advisers first reported a position in VIVO in Q4 2018 and held it in 2 quarters. The position peaked at $1.69M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

FNY Investment Advisers reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
FNY Investment Advisers sold 51,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.69M.
FNY Investment Advisers first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 2 quarters.
FNY Investment Advisers's Meridian Bioscience Inc position peaked at $1.69M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on FNY Investment Advisers's 13F filing for Q1 2023, filed 12 Apr 2023.